- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00677690
Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)
November 4, 2011 updated by: Ercole Zanotti, Fondazione Salvatore Maugeri
Combination of Pulmonary Rehabilitation and Neuromuscular Electrical Stimulation and in COPD Patients: a Randomized Clinical Trial of Efficacy
The purpose of this study is to elucidate whether combination of usual pulmonary rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise capacity in patients affected by chronic obstructive pulmonary disease (COPD).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Neuromuscular electrical stimulation (NMES) has been extensively used as technique to improve muscle function in different areas of rehabilitation, however it seems to be more appropriate in critical care situation, while its use in more able patients is of uncertain benefit.
In other words, NMES seems to be particularly effective in severely deconditioned and bed ridden patients.
We therefore carried out a randomised trial to compare the efficacy of combination of NMES and PR (NM+PR) with combination of sham stimulation and PR (SS+PR) in a large population of moderately impaired COPD patients.
Primary outcome was evaluation of effect of NMES on quadriceps strength and on exercise capacity.
Secondary outcome was evaluation of effect of NMES on symptoms (dyspnoea) and quality of life.
Study Type
Interventional
Enrollment (Actual)
83
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pavia
-
Montescano, Pavia, Italy, 27040
- Fondazione Salvatore Maugeri
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of COPD
- Must be able to walk
Exclusion Criteria:
- Previous or current diagnosis of chronic respiratory failure
- A history of diseases other than COPD, in particular neurological disease
- Need for treatment with systemic steroids during the rehabilitation period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: NM+PR
Patients undergone to combination of neuromuscular stimulation and pulmonary rehabilitation (NM+PR)
|
NMES was applied by means of a commercially available four channel electrostimulator which generated a symmetrical biphasic pulsed current.
Each session lasted 30 minutes and was performed 5 days/week for 5 weeks.
Other Names:
|
Placebo Comparator: SS+PR
Patients undergone to pulmonary rehabilitation
|
Sham stimulation was performed with the same modality and time, but the stimulus was set up at 5 Hz.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise Capacity
Time Frame: 5 weeks
|
6 minute walk test(6MWT)
|
5 weeks
|
Quadriceps Strength
Time Frame: 5 weeks
|
Quadriceps strength was assessed by means of Sit to Stand Test (STST).
The subjects held their arms stationary by putting their hands on their hips.
The subjects were asked to complete the sitting and standing positions without using the arms for support while rising and sitting.
Once instructed, subjects stand upright and without delay sit down again, repeating the procedure as many times as possible in a 1 min period.
The number of completed repetitions was recorded.
The subjects were permitted to use rest periods to complete 1 min.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyspnoea
Time Frame: 5 weeks
|
The modified Medical Research Council (MMRC) scale was used for rating dyspnoea.
MMRC is a five-point scale based on degrees of various physical activities that precipitate breathlessness.
Scores on the MMRC dyspnoea scale can range from 0 (normal) to 4.
|
5 weeks
|
Quality of Life
Time Frame: 5 weeks
|
St. George's respiratory questionnaire is a standardized self-administered airways disease-specific questionnaire divided into three subscales: symptoms (eight items), activity (16 items), and impacts (26 items).
For each subscale and for the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).
|
5 weeks
|
Respiratory Function
Time Frame: 5 weeks
|
forced expiratory volume in 1 second (FEV1)
|
5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ercole zanotti, MD, Fondazione Maugeri
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2007
Primary Completion (Actual)
March 1, 2008
Study Completion (Actual)
January 1, 2009
Study Registration Dates
First Submitted
May 8, 2008
First Submitted That Met QC Criteria
May 12, 2008
First Posted (Estimate)
May 14, 2008
Study Record Updates
Last Update Posted (Estimate)
November 16, 2011
Last Update Submitted That Met QC Criteria
November 4, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on neuromuscular electrical stimulation (NMES)
-
Federal University of Health Science of Porto AlegreNot yet recruitingAnterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament Reconstruction RehabilitationBrazil
-
Research Institute for Complex Problems of Cardiovascular...UnknownHeart Failure | Sarcopenia | Peripheral Artery Disease | Exercise IntoleranceRussian Federation
-
University of VermontRecruitingCommunity-acquired Pneumonia | COPD Exacerbation AcuteUnited States
-
Dr. Soetomo General HospitalCompletedChronic Heart FailureIndonesia
-
Maastricht University Medical CenterTerminatedImmobilization | Muscle Disuse AtrophyNetherlands
-
Federal University of Rio Grande do SulEnrolling by invitation
-
Vastra Gotaland RegionGöteborg UniversityNot yet recruitingPhysical Disability | Achilles Tendon RuptureSweden
-
Research Institute for Complex Problems of Cardiovascular...UnknownSarcopenia | Heart Failure, SystolicRussian Federation
-
University of PittsburghKing Fahad Specialist Hospital Dammam; Saudi Arabian Cultural MissionCompleted
-
University of VermontCompletedKnee OsteoarthritisUnited States